List of Tables
Table 1. Global Tuberculosis Vaccine Treatment Sales (K Dose) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Tuberculosis Vaccine Treatment Sales (K Dose) Comparison by Application (2021-2027)
Table 3. Global Tuberculosis Vaccine Treatment Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Tuberculosis Vaccine Treatment Covered in This Study
Table 5. Global Tuberculosis Vaccine Treatment Sales (K Dose) of Key Manufacturers (2016-2021)
Table 6. Global Tuberculosis Vaccine Treatment Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Tuberculosis Vaccine Treatment Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Tuberculosis Vaccine Treatment Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Tuberculosis Vaccine Treatment Average Price (USD/K Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Tuberculosis Vaccine Treatment Manufacturing Sites and Area Served
Table 11. Manufacturers Tuberculosis Vaccine Treatment Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Tuberculosis Vaccine Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Vaccine Treatment as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Tuberculosis Vaccine Treatment Sales by Region (2016-2021) & (K Dose)
Table 16. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2016-2021)
Table 17. Global Tuberculosis Vaccine Treatment Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose)
Table 19. North America Tuberculosis Vaccine Treatment Sales Market Share by Country (2016-2021)
Table 20. North America Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Tuberculosis Vaccine Treatment Revenue Market Share by Country (2016-2021)
Table 22. Europe Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose)
Table 23. Europe Tuberculosis Vaccine Treatment Sales Market Share by Country (2016-2021)
Table 24. Europe Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Tuberculosis Vaccine Treatment Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Tuberculosis Vaccine Treatment Sales by Region (2016-2021) & (K Dose)
Table 27. Asia Pacific Tuberculosis Vaccine Treatment Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Tuberculosis Vaccine Treatment Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Tuberculosis Vaccine Treatment Revenue Market Share by Region (2016-2021)
Table 30. Latin America Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose)
Table 31. Latin America Tuberculosis Vaccine Treatment Sales Market Share by Country (2016-2021)
Table 32. Latin America Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Tuberculosis Vaccine Treatment Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose)
Table 35. Middle East and Africa Tuberculosis Vaccine Treatment Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Tuberculosis Vaccine Treatment Revenue Market Share by Country (2016-2021)
Table 38. Global Tuberculosis Vaccine Treatment Sales (K Dose) by Type (2016-2021)
Table 39. Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021)
Table 40. Global Tuberculosis Vaccine Treatment Revenue (Million US$) by Type (2016-2021)
Table 41. Global Tuberculosis Vaccine Treatment Revenue Share by Type (2016-2021)
Table 42. Global Tuberculosis Vaccine Treatment Price (USD/K Dose) by Type (2016-2021)
Table 43. Global Tuberculosis Vaccine Treatment Sales (K Dose) by Application (2016-2021)
Table 44. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021)
Table 45. Global Tuberculosis Vaccine Treatment Revenue (Million US$) by Application (2016-2021)
Table 46. Global Tuberculosis Vaccine Treatment Revenue Share by Application (2016-2021)
Table 47. Global Tuberculosis Vaccine Treatment Price (USD/K Dose) by Application (2016-2021)
Table 48. Merck Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 51. Merck Tuberculosis Vaccine Treatment Product
Table 52. Merck Recent Developments/Updates
Table 53. Japan BCG Lab Corporation Information
Table 54. Japan BCG Lab Description and Business Overview
Table 55. Japan BCG Lab Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 56. Japan BCG Lab Tuberculosis Vaccine Treatment Product
Table 57. Japan BCG Lab Recent Developments/Updates
Table 58. Serum Institute of India Corporation Information
Table 59. Serum Institute of India Description and Business Overview
Table 60. Serum Institute of India Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 61. Serum Institute of India Tuberculosis Vaccine Treatment Product
Table 62. Serum Institute of India Recent Developments/Updates
Table 63. AJ Vaccines Corporation Information
Table 64. AJ Vaccines Description and Business Overview
Table 65. AJ Vaccines Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 66. AJ Vaccines Tuberculosis Vaccine Treatment Product
Table 67. AJ Vaccines Recent Developments/Updates
Table 68. BioFarma Corporation Information
Table 69. BioFarma Description and Business Overview
Table 70. BioFarma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 71. BioFarma Tuberculosis Vaccine Treatment Product
Table 72. BioFarma Recent Developments/Updates
Table 73. GreenSignal Bio Pharma Corporation Information
Table 74. GreenSignal Bio Pharma Description and Business Overview
Table 75. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 76. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product
Table 77. GreenSignal Bio Pharma Recent Developments/Updates
Table 78. China National Biotec Corporation Information
Table 79. China National Biotec Description and Business Overview
Table 80. China National Biotec Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 81. China National Biotec Tuberculosis Vaccine Treatment Product
Table 82. China National Biotec Recent Developments/Updates
Table 83. Biomed Lublin Corporation Information
Table 84. Biomed Lublin Description and Business Overview
Table 85. Biomed Lublin Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 86. Biomed Lublin Tuberculosis Vaccine Treatment Product
Table 87. Biomed Lublin Recent Developments/Updates
Table 88. Taj Pharmaceuticals Corporation Information
Table 89. Taj Pharmaceuticals Description and Business Overview
Table 90. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 91. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product
Table 92. Taj Pharmaceuticals Recent Developments/Updates
Table 93. Ataulpho de Paiva Corporation Information
Table 94. Ataulpho de Paiva Description and Business Overview
Table 95. Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 96. Ataulpho de Paiva Tuberculosis Vaccine Treatment Product
Table 97. Ataulpho de Paiva Recent Developments/Updates
Table 98. IVAC Corporation Information
Table 99. IVAC Description and Business Overview
Table 100. IVAC Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 101. IVAC Tuberculosis Vaccine Treatment Product
Table 102. IVAC Recent Developments/Updates
Table 103. Queen Saovabha Mem. Inst Corporation Information
Table 104. Queen Saovabha Mem. Inst Description and Business Overview
Table 105. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 106. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product
Table 107. Queen Saovabha Mem. Inst Recent Developments/Updates
Table 108. Microgen Corporation Information
Table 109. Microgen Description and Business Overview
Table 110. Microgen Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 111. Microgen Tuberculosis Vaccine Treatment Product
Table 112. Microgen Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Tuberculosis Vaccine Treatment Distributors List
Table 116. Tuberculosis Vaccine Treatment Customers List
Table 117. Tuberculosis Vaccine Treatment Market Trends
Table 118. Tuberculosis Vaccine Treatment Growth Drivers
Table 119. Tuberculosis Vaccine Treatment Market Challenges
Table 120. Tuberculosis Vaccine Treatment Market Restraints
Table 121. Global Tuberculosis Vaccine Treatment Sales Forecast by Type (2022-2027) & (K Dose)
Table 122. Global Tuberculosis Vaccine Treatment Sales Market Share Forecast by Type (2022-2027)
Table 123. Global Tuberculosis Vaccine Treatment Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 124. Global Tuberculosis Vaccine Treatment Revenue Market Share Forecast by Type (2022-2027)
Table 125. Global Tuberculosis Vaccine Treatment Sales Forecast by Application (2022-2027) & (K Dose)
Table 126. Global Tuberculosis Vaccine Treatment Sales Market Share Forecast by Application (2022-2027)
Table 127. Global Tuberculosis Vaccine Treatment Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 128. Global Tuberculosis Vaccine Treatment Revenue Market Share Forecast by Application (2022-2027)
Table 129. Global Tuberculosis Vaccine Treatment Sales Forecast by Region (2022-2027) & (K Dose)
Table 130. Global Tuberculosis Vaccine Treatment Sales Market Share Forecast by Region (2022-2027)
Table 131. Global Tuberculosis Vaccine Treatment Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 132. Global Tuberculosis Vaccine Treatment Revenue Market Share Forecast by Region (2022-2027)
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tuberculosis Vaccine Treatment
Figure 2. Global Tuberculosis Vaccine Treatment Market Share by Type in 2020 & 2027
Figure 3. Immune Vaccine Product Picture
Figure 4. Therapy Vaccine Product Picture
Figure 5. Global Tuberculosis Vaccine Treatment Market Share by Application in 2020 & 2027
Figure 6. Self-Procurement
Figure 7. UNICEF
Figure 8. Other
Figure 9. Global Tuberculosis Vaccine Treatment Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Tuberculosis Vaccine Treatment Market Size 2016-2027 (US$ Million)
Figure 11. Global Tuberculosis Vaccine Treatment Sales 2016-2027 (K Dose)
Figure 12. Global Tuberculosis Vaccine Treatment Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Tuberculosis Vaccine Treatment Sales Share by Manufacturers in 2020
Figure 14. Global Tuberculosis Vaccine Treatment Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Tuberculosis Vaccine Treatment Players: Market Share by Revenue in 2020
Figure 16. Tuberculosis Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2016-2021)
Figure 18. Global Tuberculosis Vaccine Treatment Sales Market Share by Region in 2020
Figure 19. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2016-2021)
Figure 20. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region in 2020
Figure 21. U.S. Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Tuberculosis Vaccine Treatment by Type (2016-2021)
Figure 46. Sales Market Share of Tuberculosis Vaccine Treatment by Application (2016-2021)
Figure 47. Sales Market Share of Tuberculosis Vaccine Treatment by Application in 2020
Figure 48. Revenue Share of Tuberculosis Vaccine Treatment by Application (2016-2021)
Figure 49. Revenue Share of Tuberculosis Vaccine Treatment by Application in 2020
Figure 50. Manufacturing Cost Structure of Tuberculosis Vaccine Treatment
Figure 51. Manufacturing Process Analysis of Tuberculosis Vaccine Treatment
Figure 52. Tuberculosis Vaccine Treatment Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed